These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA). Eissa A; Krass I; Bajorek BV J Clin Pharm Ther; 2012 Dec; 37(6):620-9. PubMed ID: 22708668 [TBL] [Abstract][Full Text] [Related]
15. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial. Saposnik G; Demchuk A; Tu JV; Johnston SC; J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):876-82. PubMed ID: 23102741 [TBL] [Abstract][Full Text] [Related]
16. Safety of intravenous thrombolytic use in four emergency departments without acute stroke teams. Scott PA; Frederiksen SM; Kalbfleisch JD; Xu Z; Meurer WJ; Caveney AF; Sandretto A; Holden AB; Haan MN; Hoeffner EG; Ansari SA; Lambert DP; Jaggi M; Barsan WG; Silbergleit R Acad Emerg Med; 2010 Oct; 17(10):1062-71. PubMed ID: 21040107 [TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Graham GD Stroke; 2003 Dec; 34(12):2847-50. PubMed ID: 14605319 [TBL] [Abstract][Full Text] [Related]
18. In-hospital delays to stroke thrombolysis: paradoxical effect of early arrival. Romano JG; Muller N; Merino JG; Forteza AM; Koch S; Rabinstein AA Neurol Res; 2007 Oct; 29(7):664-6. PubMed ID: 18173904 [TBL] [Abstract][Full Text] [Related]
19. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator. Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916 [TBL] [Abstract][Full Text] [Related]
20. Multicenter Study of Adverse Events After Intravenous Tissue-Type Plasminogen Activator Treatment of Acute Ischemic Stroke. Fernandez-Gotico H; Lightfoot T; Meighan M J Neurosci Nurs; 2017 Feb; 49(1):31-36. PubMed ID: 28060219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]